Cardiovascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Disease stocks.

Cardiovascular Disease Stocks Recent News

Date Stock Title
Nov 20 GILD Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript)
Nov 20 CAPR Capricor wins key EU designations for the lead asset
Nov 20 CAPR Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency
Nov 19 LH Labcorp gets new finance chief
Nov 19 LH Labcorp CFO Glenn Eisenberg Announces Plans to Retire
Nov 18 GILD Gilead’s Livdelzi shows promise in PBC clinical trial
Nov 18 SMLR Semler Scientific buys additional 215 bitcoins
Nov 18 SMLR Semler Scientific® Announces BTC and ATM Activity Raised $21.5 million; Purchased Additional 215 BTC; Now Holds 1,273 BTC with BTC Yield of 37.3%
Nov 18 GRCE GRCE: FY:25 Second Quarter Results
Nov 16 CAPR Is Capricor Therapeutics (CAPR) the Best Multibagger Stock to Buy Heading into 2025?
Nov 15 GILD Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease
Nov 15 GRCE Grace Therapeutics And 2 Other US Penny Stocks To Watch
Nov 15 GILD Gilead’s Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis
Nov 15 LH Is Labcorp Stock a Good Pick for Your Portfolio Right Now?
Nov 15 SMLR Semler Scientific Independent Chairman of the board Acquires 8.7% More Stock
Nov 15 CAPR Capricor Therapeutics Third Quarter 2024 Earnings: Misses Expectations
Nov 14 GILD Gilead, Vertex initiated as new big biotech buys at Citi
Nov 14 GILD Citi initiates coverage on 5 new biotech stocks
Nov 14 CAPR Q3 2024 Capricor Therapeutics Inc Earnings Call
Nov 14 GILD Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet
Cardiovascular Disease

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.

Browse All Tags